Johnson & Johnson has roped in Jessica Moore as Vice President of Investor Relations, effective November 1, 2021. She will report to Joseph Wolk, Executive Vice President and Chief Financial Officer of the Company. With 20 years of experience across Sales Operations, Corporate and Regional positions, Moore was most recently served as the Vice President and Chief…
Johnson & Johnson announced that Alex Gorsky, currently Chairman and Chief Executive Officer, will serve as Executive Chairman of Johnson & Johnson and transition the Chief Executive Officer role to Joaquin Duato, currently Vice Chairman of the Company’s Executive Committee, effective January 3, 2022. Following the transition of the Chief Executive Officer role, Duato will also…
Johnson & Johnson announced that Dr. Nadja West, a retired U.S. Army lieutenant general and former U.S. Army Surgeon General has been appointed to its Board of Directors. Commenting on the appointment, Alex Gorsky, Chairman and Chief Executive Officer, Johnson & Johnson, said, “I am pleased to welcome Dr. Nadja West to Johnson & Johnson’s…
Johnson & Johnson announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies. According to the press release, the initiation of the ENSEMBLE trial follows positive interim results from the Company’s Phase 1/2a clinical study, which demonstrated that the safety…
Johnson & Johnson announced it has entered into a definitive agreement to acquire Momenta Pharmaceuticals, a company that discovers and develops novel therapies for immune-mediated diseases, in an all cash transaction for approximately $6.5 billion. This acquisition provides an opportunity for the Janssen Pharmaceutical Companies of Johnson & Johnson to broaden its leadership in immune-mediated…
The Carlyle-group backed Ortho Clinical Diagnostics recently announced that it has appointed Joseph M. Busky as Chief Financial Officer, effective July 7, 2020. Busky, who previously served as Chief Financial Officer for Vyaire Medical, Inc., has over 30 years of experience in corporate and operational finance for large, global companies across diagnostics, medical devices, telecom,…
Johnson & Johnson has announced a collaboration between the Janssen Pharmaceutical Companies of Johnson & Johnson and Emergent BioSolutions, Inc. to support the manufacturing of its lead investigational COVID-19 vaccine candidate. The collaboration is the first in a series of prospective global collaboration agreements designed to accelerate manufacturing of Johnson & Johnson’s COVID-19 vaccine candidate,…
Good mental health at work and good management go hand in hand and there is strong evidence that workplaces with high levels of mental well being are more productive.